Photobiomodulation therapy has important implications for health that many are still under-informed about. In this interview, photodynamic therapy researcher Michael Hamblin, Ph.D., who is an expert in this area, sets out to improve our understanding of this important field.
Hamblin is a researcher and associate professor of dermatology at Harvard Medical School. He’s also a principal investigator at The Wellman Center for Photomedicine at Massachusetts General Hospital, and a member of the Harvard-MIT Division of Health Sciences and Technology.
Infrared therapy is one aspect of photobiomodulation, which covers light of all wavelengths — visible light, and light from spectral regions including ultraviolet, blues through the green, red and into the near-, mid- and far-infrared wavelengths.
One of the most beneficial wavelengths of light is the near-infrared (810 to 830 nm), which penetrates deep into your body and has many biological effects. Far-infrared is absorbed by water, which is why it cannot penetrate as deeply
Far-infrared exerts biological effects primarily by altering protein structures, mediated by nanostructured water
Near-infrared primarily targets the cytochrome c oxidase in the mitochondria, causing dissociation of nitric oxide and increasing electron transport and ATP synthesis
If you are interested in learning more about Photobiomodulation, please contact our office to make an appointment with Dr. Hotchner. (305) 856-8185
“Our mission is to educate, support, and work with the patient as a team to help each person to heal spiritually, mentally, emotionally, and physically. I do this out of my passion to help each person rediscover their wholeness, their true identity as God’s creation and child.”
|Mon – Tues – Th – Fri||8 a.m. – 4 p.m|
|Wednesday||9 a.m – 12 noon|
|Closed for lunch||12 noon – 1 p.m.|